title: Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
authors.affiliation: Charitx00E9; - Universitx00E4;tsmedizin Berlin, Campus Virchow Klinikum, Medizinische Klinik m.S. Hx00E4;matologie und Onkologie, Berlin, Germany.
authors.forename: Jaspal
authors.initials: J
authors.lastname: Kaeda
authors.forename: Frauke
authors.initials: F
authors.lastname: Ringel
authors.forename: Christian
authors.initials: C
authors.lastname: Oberender
authors.forename: Martin
authors.initials: M
authors.lastname: Gresse
authors.forename: Leila
authors.initials: L
authors.lastname: Amini
authors.forename: Michaela
authors.initials: M
authors.lastname: Schwarz
authors.forename: Bernd
authors.initials: B
authors.lastname: Dörken
authors.forename: Philipp
authors.initials: P
authors.lastname: le Coutre
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069439:Dasatinib / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics* / Q000378:metabolism; D015870:Gene Expression; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011743:Pyrimidines / Q000627:therapeutic use; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: C581634:BCR-ABL1 fusion protein, human; C438151:MSI2 protein, human; D011743:Pyrimidines; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D000068877:Imatinib Mesylate; D007372:Interferons; D016044:Fusion Proteins, bcr-abl; C498826:nilotinib; D000069439:Dasatinib